PNC Financial Services Group’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.2K | Buy |
2,234
+28
| +1% | +$379 | ﹤0.01% | 3369 |
|
|
2025
Q1 | $35K | Buy |
2,206
+21
| +1% | +$333 | ﹤0.01% | 3284 |
|
|
2024
Q4 | $26.9K | Sell |
2,185
-26
| -1% | -$320 | ﹤0.01% | 3395 |
|
|
2024
Q3 | $26.8K | Hold |
2,211
| – | – | ﹤0.01% | 3377 |
|
|
2024
Q2 | $25.9K | Hold |
2,211
| – | – | ﹤0.01% | 3353 |
|
|
2024
Q1 | $28.5K | Sell |
2,211
-1,911
| -46% | -$24.7K | ﹤0.01% | 3260 |
|
|
2023
Q4 | $35.4K | Buy |
4,122
+4,099
| +17,822% | +$35.3K | ﹤0.01% | 3136 |
|
|
2023
Q3 | $219 | Buy |
+23
| New | +$219 | ﹤0.01% | 4529 |
|